Arlington Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-359
| Closed | -$209K | – | 157 |
|
|
2023
Q4 | $209K | Sell |
359
-98
| -21% | -$57.1K | 0.06% | 86 |
|
|
2023
Q3 | $245K | Sell |
457
-282
| -38% | -$151K | 0.1% | 77 |
|
|
2023
Q2 | $347K | Buy |
739
+132
| +22% | +$61.9K | 0.05% | 105 |
|
|
2023
Q1 | $208K | Buy |
607
+209
| +53% | +$71.8K | 0.03% | 131 |
|
|
2022
Q4 | $146K | Buy |
398
+99
| +33% | +$36.2K | 0.02% | 113 |
|
|
2022
Q3 | $97K | Sell |
299
-194
| -39% | -$62.9K | 0.04% | 137 |
|
|
2022
Q2 | $160K | Buy |
493
+165
| +50% | +$53.6K | 0.05% | 116 |
|
|
2022
Q1 | $94K | Buy |
328
+29
| +10% | +$8.31K | 0.03% | 186 |
|
|
2021
Q4 | $83K | Buy |
+299
| New | +$83K | 0.02% | 223 |
|
|
2018
Q3 | – | Sell |
-228
| Closed | -$19K | – | 219 |
|
|
2018
Q2 | $19K | Hold |
228
| – | – | 0.02% | 101 |
|
|
2018
Q1 | $18K | Buy |
+228
| New | +$18K | 0.02% | 108 |
|